Literature DB >> 30672511

Response to comment on: Validating the pachychoroid disease spectrum using multimodal imaging.

Guruprasad Ayachit1, Apoorva Ayachit1, Harsha Nadgir1, Shrinivas Joshi1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30672511      PMCID: PMC6376811          DOI: 10.4103/ijo.IJO_1870_18

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Sir, We thank Sheth et al. for their interest in our case. They present a very well-illustrated follow-up of a case of pachychoroid over 4 years.[1] In their case, there is a progression of pachychoroid pigment epitheliopathy (PPE) to central serous chorioretinopathy (CSC), pachychoroid neovasculopathy (PCN), and finally polypoidal choroidal vasculopathy (PCV). This progression is well known in the pathogenesis of pachychoroid disease spectrum. The novelty of our case, however, was simultaneous presentation of both CSC and PCV along with emphasis on optical coherence tomography angiography features. Polyps and choroidal neovascularization in the setting of chronic CSC are well known.[2] This aspect is getting increased attention since the introduction of the concept of pachychoroid. We wish to reiterate that the key focus of our case was the possibility of simultaneously having both CSC and PCV as also illustrated in a series by Manayath et al.[3] We feel that Dr. Sheth's case would have been an interesting adjunct to our case had they shown an example where there were PPE, CSC, neovasculopathy, and PCV at the same point in time. We agree that our patient did not have PCN in addition to having PPE, CSC, and PCV. Their case merely shows progression of pachychoroid and not simultaneous presentation like in our case. It seems like an addition only because of the demonstration of imaging features of PCN, in a longitudinal follow-up.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  3 in total

1.  POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.

Authors:  George J Manayath; Vanee Sheth Shah; Veerappan R Saravanan; Venkatapathy Narendran
Journal:  Retina       Date:  2018-06       Impact factor: 4.256

2.  Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathy.

Authors:  Han Sang Park; In Taek Kim
Journal:  Korean J Ophthalmol       Date:  2012-01-14

3.  Comment on: Validating the pachychoroid disease spectrum using multimodal imaging.

Authors:  Jay U Sheth; Anantharaman Giridhar
Journal:  Indian J Ophthalmol       Date:  2019-02       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.